SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-24-028509
Filing Date
2024-02-28
Accepted
2024-02-28 08:43:07
Documents
7
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 POSASR tm247340-1_posasr.htm POSASR 273079
2 EXHIBIT 5.1 tm247340d2_ex5-1.htm EX-5.1 29358
3 EXHIBIT 23.1 tm247340d2_ex23-1.htm EX-23.1 2600
4 EX-FILING FEES tm247340d2_ex-filingfees.htm EX-FILING FEES 29083
5 GRAPHIC tm247340d2_ex5-1img001.jpg GRAPHIC 5853
6 GRAPHIC tm247340d2_ex5-1img002.jpg GRAPHIC 28082
7 GRAPHIC lg_mersanatherapeu-4c.jpg GRAPHIC 27276
  Complete submission text file 0001104659-24-028509.txt   420041
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-271766 | Film No.: 24690459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)